SVF Pauling (Cayman) Ltd sold $116.4M of Relay Therapeutics (RLAY)

Executed Aug 25, disclosed Aug 28, 3 days later, against a two-business-day limit.

Value, as filed

$116.4M

6,000,000 sh × $19.40

Executed

Aug 25

the trade date, as filed

Disclosed

Aug 28

3 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SL SVF Pauling (Cayman) Ltd 10% owner profile →

SVF Pauling (Cayman) Ltd (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $116.4M of RLAY (6,000,000 sh × $19.40, as filed), executed Aug 25.

The name

RLAY

Relay Therapeutics, Inc. RLAY · Healthcare · 32 filings in 24 months ticker →

Healthcare · Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→